stockrowTeleflex Incorporated
TFX Healthcare Medical Instruments & Supplies
Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.
- Revenue
- +28.9%
- EPS
- −17.3%
- Free cash flow
- +220.1%
- Total debt
- +47.7%
Quarter to June 2026, against a year earlier
Follow TFX
Alert me
Teleflex Incorporated (TFX) Return on invested capital
Teleflex Incorporated's return on invested capital over the twelve months to 30 June 2026 was 0.51%, down 0.9 percentage points from fiscal 2025 (1.37%). Over the past ten years it has ranged from 1.14% (fiscal 2024) to 7.59% (fiscal 2016); the current reading is higher than 18% of that period. That is above the Medical Instruments & Supplies industry median of 0.13% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 1.37% | 0.23 |
| FY2024 | 1.14% | (1.49) |
| FY2023 | 2.63% | (3.11) |
| FY2022 | 5.74% | (0.76) |
| FY2021 | 6.50% | 1.64 |
| FY2020 | 4.86% | (0.88) |
| FY2019 | 5.74% | 1.11 |
| FY2018 | 4.63% | (0.72) |
| FY2017 | 5.35% | (2.24) |
| FY2016 | 7.59% | 0.36 |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| NVST Envista Holdings Corporation compare | 13.6% |
| ATR AptarGroup, Inc. compare | 7.83% |
| MMSI Merit Medical Systems, Inc. compare | 6.87% |
| AVTR Avantor, Inc. compare | 3.36% |
| ICUI ICU Medical, Inc. compare | 2.27% |
| BLCO Bausch + Lomb Corporation compare | 2.16% |
| TFX Teleflex Incorporated | 0.51% |
| MMED MiniMed Group, Inc. compare | −1.61% |
| PLSE Pulse Biosciences, Inc compare | −37.0% |
| Medical Instruments & Supplies industry median | 0.13% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on TFX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement